Table 2.
Laboratory parameters, mood and disease characteristics of the respondents in the total sample and based on frequency of sleepiness.
| Parameter | Total, n (%) or median (25–75 percentile) | Sleepiness <3 times/ week, n (%) or median (25–75 percentile) | Sleepiness ≥3 times/ week, n (%) or median (25–75 percentile) | p |
|---|---|---|---|---|
| Laboratory parameters | ||||
| Fasting glucose, mmol/l | 5,07 (4,60-5,55) | 5.07 (4.60; 5.55) | 5.07 (4.60; 5.55) | 0.894 |
| Creatinine, mmol/l | 67,1 (61,0-74,7) | 67.30 (61.00; 74.90) | 66.20 (60.30; 73.60) | <0.001 |
| GFR, ml per minute | 100,5(90,9-110,6) | 100,4 (90,6–110,5) | 99,9 (90,4–10,9) | р = 0,387 |
| Uric acid, mmol/l | 293 (240–360) | 295.00 (240.00; 360.00) | 290.00 (233.00; 350.00) | 0.024 |
| Cholesterol, mmol/l | 5,29 (4.55–6.07) | 5.28 (4.55; 6.07) | 5.30 (4.54; 6.11) | 0.604 |
| LDL, mmol/l | 3,29 (2.64–4.01) | 3.30 (2.65; 4.00) | 3.29 (2.63; 4.03) | 0.570 |
| HDL, mmol/l | 1,36 (1.16–1.61) | 1.36 (1.15; 1.61) | 1.39 (1.18; 1.65) | <0.001 |
| Triglycerides, mmol/l | 1,17 (0.83–1.71) | 1.18 (0.83; 1.72) | 1.13 (0.82; 1.68) | 0.012 |
| Mood | ||||
| Anxiety | ||||
| Abnormal | 18,4 (17.8–19.1) | 1900 (17.0%) | 541 (25.9%) | <0.001 |
| Borderline | 27,9 (27.1–28.7) | 3,049 (27.3%) | 644 (30.8%) | |
| Normal | 53,7 (52.8–54.5) | 6,208 (55.6%) | 905 (43.3%) | |
| Depression | ||||
| Abnormal | 9,3 (8.8–9.8) | 1,026 (9.2%) | 209 (10.0%) | <0.001 |
| Borderline | 17,1 (16.5–17.8) | 1850 (16.6%) | 424 (20.3%) | |
| Normal | 73,5 (72.8–74.3) | 8,286 (74.2%) | 1,458 (69.7%) | |
| SBP, mm Hg | 130 (119–143) | 130 (119–143) | 129 (117; 142) | 0.009 |
| DBP, mm Hg | 81 (74–89) | 81 (74–89) | 80 (73; 89) | 0.074 |
| HR, beat per minute | 73 (67–79) | 73 (67–79) | 72,0 (66–79) | 0.032 |
| Arthrosis | 4,701 (35,5) | 4,453 (35,7) | 248 (31,8) | χ2 = 4,995 p = 0,025 |
| Rheumatoid arthritis | 799 (6,0) | 739 (5,9) | 60 (7,7) | χ2 = 4,011 p = 0,045 |
| Chronic bronchitis | 1901 (14,3) | 1768 (14,2) | 133 (17,0) | χ2 = 4,880 p = 0,027 |
| Asthma | 415 (3,1) | 380 (3,0) | 35 (4,5) | χ2 = 4,991 p = 0,029 |
| Hypertension | 6,194 (46,7) | 5,804 (46,5) | 390 (49,9) | χ2 = 3,420 p = 0,038 |
| Diabetes mellitus | 559 (4,2) | 515 (4,1) | 44 (5,6) | χ2 = 4,122 p = 0,042 |
| Myocardial infarction | 271 (2,0) | 253 (2,0) | 18 (2,3) | χ2 = 0,281 p = 0,596 |
| Stroke | 258 (1,9) | 234 (1,9) | 24 (3,1) | χ2 = 5,519 p = 0,019 |
| Coronary artery disease | 2,382 (18,0) | 2,179 (17,5) | 203 (26,0) | χ2 = 13,704 p < 0,001 |
| Other heart diseases | 1,078 (8,1) | 984 (7,9) | 94 (12,0) | χ2 = 16,921 p < 0,001 |
| Arrhythmia | 2,382 (18,0) | 2,179 (17,5) | 203 (26,0) | χ2 = 36,227 p < 0,001 |
| Ulcer disease | 1,655 (12,5) | 1,528 (12,2) | 127 (16,3) | χ2 = 10,825 p = 0,001 |
| Liver, gallbladder, and gastrointestinal tract conditions | 4,924 (37,1) | 4,579 (36,7) | 345 (44,2) | χ2 = 17,546 p < 0,001 |
| Renal disease | 2,440 (18,4) | 2,246 (18,0) | 194 (24,8) | χ2 = 22,858 p < 0,001 |
| Thyroid disease | 1,649 (12,4) | 1,526 (12,2) | 123 (15,7) | χ2 = 8,339 p = 0,004 |
| Parkinson’s disease | 34 (0,3) | 33 (0,3) | 1 (0,1) | χ2 = 0,535 p = 0,464 |
| Organ transplant | 109 (0,8) | 99 (0,8) | 10 (1,3) | χ2 = 2,135 p = 0,144 |
| Cancer | 396 (3,0) | 364 (2,9) | 32 (4,1) | χ2 = 3,526 p = 0,06 |
DBP, Diastolic blood pressure; GFR, Glomerular filtration rate; HDL, High-density lipoprotein; HR, Heart rate; LDL, Low-density lipoprotein; SBP, Systolic blood pressure.